氧气在微胶囊膜中的扩散行为将直接决定微囊内细胞的生长代谢行为。以海藻酸钠-壳聚糖聚电解质复合平板膜为研究模型,利用渗透池法,重点考察溶氧在膜中的扩散行为及其影响因素。结果显示:复合膜的扩散系数和孔隙率均低于海藻酸钙,复合...氧气在微胶囊膜中的扩散行为将直接决定微囊内细胞的生长代谢行为。以海藻酸钠-壳聚糖聚电解质复合平板膜为研究模型,利用渗透池法,重点考察溶氧在膜中的扩散行为及其影响因素。结果显示:复合膜的扩散系数和孔隙率均低于海藻酸钙,复合膜中溶氧扩散系数为(7~13)×10 10m2 s 1,为水中的23.3%~43.3%,孔隙率为93%~97%;扩散系数随海藻酸钠特性黏度的增大而减小,随壳聚糖分子量的增大而减小。微胶囊膜是氧传质主要的阻力部位,孔隙率、三维结构和材料极性是影响扩散性能的重要因素,改变海藻酸钠特性黏度和壳聚糖分子量可以改变膜孔隙率、结构和材料极性,进而调节膜扩散性能。展开更多
To overcome the fast or burst release of hydrophilic drugs from hydrophilic alginate-based carriers,hydrophobic molecule(vinyl acetate,VAc)was grafted on alginate(Alg),which was further used to prepare drug carriers.A...To overcome the fast or burst release of hydrophilic drugs from hydrophilic alginate-based carriers,hydrophobic molecule(vinyl acetate,VAc)was grafted on alginate(Alg),which was further used to prepare drug carriers.Amphiphilic Alg-g-PVAc hydrogel beads were firstly prepared by emulsification/internal gelation technique for the loading of bovine serum albumin(BSA).Then,chitosan was coated on the surface of beads to form novel amphiphilic Alg-g-PVAc/chitosan(Alg-g-PVAc/CS)microcapsules.The BSA-loading amphiphilic Alg-g-PVAc/chitosan(Alg-g-PVAc/CS)microcapsules display similar morphology and size to the hydrophilic alginate/chitosan(AC)microcapsules.However,the drug loading and loading efficiency of BSA in Alg-g-PVAc/CS microcapsules are higher,and the release rate of BSA from Alg-g-PVAc/CS microcapsules is slower.The results demonstrate that the introduction of hydrophobic PVAc on alginate can effectively help retard the release of BSA,and the higher degree of substitution is,the slower the release rate is.In addition,the complex membrane can also be adjusted to delay the release of BSA.As a whole,amphiphilic sodium alginate-vinyl acetate/CS microparticles could be developed for macromolecular drug delivery.展开更多
文摘氧气在微胶囊膜中的扩散行为将直接决定微囊内细胞的生长代谢行为。以海藻酸钠-壳聚糖聚电解质复合平板膜为研究模型,利用渗透池法,重点考察溶氧在膜中的扩散行为及其影响因素。结果显示:复合膜的扩散系数和孔隙率均低于海藻酸钙,复合膜中溶氧扩散系数为(7~13)×10 10m2 s 1,为水中的23.3%~43.3%,孔隙率为93%~97%;扩散系数随海藻酸钠特性黏度的增大而减小,随壳聚糖分子量的增大而减小。微胶囊膜是氧传质主要的阻力部位,孔隙率、三维结构和材料极性是影响扩散性能的重要因素,改变海藻酸钠特性黏度和壳聚糖分子量可以改变膜孔隙率、结构和材料极性,进而调节膜扩散性能。
基金Supported by the National Natural Science Foundation of China(No.21276033)the Open Foundation of the State Key Laboratory of Bioactive Seaweed Substances(Nos.SKL-BASS1711,SKL-BASS1707)the National Undergraduates Innovation and Entrepreneurship Training Program of China(No.201711258000001)
文摘To overcome the fast or burst release of hydrophilic drugs from hydrophilic alginate-based carriers,hydrophobic molecule(vinyl acetate,VAc)was grafted on alginate(Alg),which was further used to prepare drug carriers.Amphiphilic Alg-g-PVAc hydrogel beads were firstly prepared by emulsification/internal gelation technique for the loading of bovine serum albumin(BSA).Then,chitosan was coated on the surface of beads to form novel amphiphilic Alg-g-PVAc/chitosan(Alg-g-PVAc/CS)microcapsules.The BSA-loading amphiphilic Alg-g-PVAc/chitosan(Alg-g-PVAc/CS)microcapsules display similar morphology and size to the hydrophilic alginate/chitosan(AC)microcapsules.However,the drug loading and loading efficiency of BSA in Alg-g-PVAc/CS microcapsules are higher,and the release rate of BSA from Alg-g-PVAc/CS microcapsules is slower.The results demonstrate that the introduction of hydrophobic PVAc on alginate can effectively help retard the release of BSA,and the higher degree of substitution is,the slower the release rate is.In addition,the complex membrane can also be adjusted to delay the release of BSA.As a whole,amphiphilic sodium alginate-vinyl acetate/CS microparticles could be developed for macromolecular drug delivery.